Shestakova, E. A. (2017). Second line therapy in type 2 diabetes: Legacy effect activation. Endocrinology Research Centre.
Cita Chicago Style (17a ed.)Shestakova, Ekaterina A. Second Line Therapy in Type 2 Diabetes: Legacy Effect Activation. Endocrinology Research Centre, 2017.
Cita MLA (8a ed.)Shestakova, Ekaterina A. Second Line Therapy in Type 2 Diabetes: Legacy Effect Activation. Endocrinology Research Centre, 2017.
Precaución: Estas citas no son 100% exactas.